PolyNovo (ASX:PNV) Presentation, CEO Sessions Sydney

Company Presentations

by Carolyn Herbert

PolyNovo Limited (ASX:PNV) CEO Paul Brennan presents at the ASX CEO Sessions in Sydney.

PolyNovo (ASX:PNV) develops unique, patented, biodegradable polymers for use in medical devices.

PolyNovo’s current focus is on developing and commercialising innovative medical devices using its NovoSorb technology in the treatment of burns, surgical wounds and Negative Pressure Wound Therapy.

Its current product is BTM (Biodegradable Temporising Matrix) – a wound dressing used to treat full-thickness wounds and burns where the dermal structure has been lost to trauma, or damaged requiring surgical removal, and requires a split-thickness skin graft for final closure.

BTM is used in five states of the US, with more to come on-stream in coming months. Initial surgeon experience with BTM has been positive, showing robust performance in challenging cases.

PolyNovo has an exclusive distribution agreement for BTM sales with Device Technologies in Australia and New Zealand.

In South Africa, Surgical Innocations is the company's exclusive distribution for BTM. Other distributor markets for potential entry in CY 2017 include Israel, India, Hong Kong and the Middle East. 

Carolyn Herbert

Finance News Network
Carolyn joined FNN in August 2015 as the Head of News and also presented the Market at Midday and the Market Wrap. With more than five years of broadcast journalism experience, Carolyn has worked as a finance anchor on the Sky News Business channel and as an anchor and reporter for ABC News. She is also a qualified corporate lawyer specialising in IPOs, takeovers and mergers and acquisitions.